Katharina Sahm
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas.
Journal: Journal of neuro-oncology
Published: September 05, 2025
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Journal: Nature communications
Published: May 01, 2025
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.
Journal: Science advances
Published: February 02, 2024
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 08, 2023
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Journal: Nature communications
Published: September 29, 2023
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 25, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
Journal: Neurological research and practice
Published: September 12, 2023
A H3K27M-targeted vaccine in adults with diffuse midline glioma.
Journal: Nature medicine
Published: February 23, 2023
Concurrent gliomas in patients with multiple sclerosis.
Journal: Communications medicine
Published: December 22, 2022
Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System.
Journal: International journal of tryptophan research : IJTR
Published: October 19, 2022
Last Updated: 09/26/2026